Seoul Pharma Co., Ltd (KOSDAQ:018680)

Seoul Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Mar 27, 2025	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Market Capitalization	36,086	30,313	15,625	17,063	8,500	19,375
Market Cap Growth	25.75%	94.00%	-8.43%	100.73%	-56.13%	-14.84%
Enterprise Value	47,706	42,437	25,732	24,980	10,983	19,038
Last Close Price	3095.00	4736.75	2413.88	2585.56	1269.20	2893.04
PE Ratio	34.26	22.73	11.05	14.45	15.68	-
PS Ratio	0.74	0.69	0.39	0.54	0.34	1.16
PB Ratio	0.93	1.49	0.81	0.94	0.56	1.34
P/TBV Ratio	1.84	1.74	0.90	1.02	0.61	1.44
P/FCF Ratio	-	18.83	-	-	-
P/OCF Ratio	9.39	6.24	7.13	13.82	-	-
EV/Sales Ratio	1.13	0.97	0.64	0.79	0.44	1.14
EV/EBITDA Ratio	-	7.44	10.84	8.28	-
EV/EBIT Ratio	30.12	22.50	10.14	20.17	35.85	-
EV/FCF Ratio	-	31.01	-	-	-
Debt / Equity Ratio	1.35	0.74	0.57	0.55	0.42	0.15
Debt / EBITDA Ratio	-	-	3.22	4.36	4.72	-
Debt / FCF Ratio	-	-	13.42	-	-	-
Asset Turnover	0.85	1.08	1.07	1.00	1.02	0.76
Inventory Turnover	4.09	4.18	4.41	4.34	4.39	3.48
Quick Ratio	0.90	1.31	1.61	1.62	2.27	2.30
Current Ratio	1.24	1.81	2.19	2.04	2.68	2.83
Return on Equity (ROE)	5.12%	6.70%	7.52%	7.10%	3.67%	-15.98%
Return on Assets (ROA)	1.99%	2.89%	4.20%	2.44%	0.79%	-8.14%
Return on Capital (ROIC)	2.38%	3.57%	5.40%	3.12%	1.01%	-10.74%
Return on Capital Employed (ROCE)	3.80%	5.80%	8.60%	4.60%	1.50%	-
Earnings Yield	2.92%	4.40%	9.05%	6.92%	6.38%	-12.95%
FCF Yield	-29.24%	-1.90%	5.31%	-28.57%	-36.25%	-14.94%
Dividend Yield	0.00%	-	-	1.55%	-	-
Payout Ratio	35.60%	23.44%	17.69%	-	-	-
Total Shareholder Return	-	-	1.55%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.